Ezra E.W. Cohen
About
Ezra E.W. Cohen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology.
According to data from OpenAlex, Ezra E.W. Cohen has authored 421 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Oncology, 191 papers in Pulmonary and Respiratory Medicine and 174 papers in Otorhinolaryngology. Recurrent topics in Ezra E.W. Cohen's work include Head and Neck Cancer Studies (174 papers), Lung Cancer Treatments and Mutations (133 papers) and Cancer Immunotherapy and Biomarkers (94 papers). Ezra E.W. Cohen is often cited by papers focused on Head and Neck Cancer Studies (174 papers), Lung Cancer Treatments and Mutations (133 papers) and Cancer Immunotherapy and Biomarkers (94 papers). Ezra E.W. Cohen collaborates with scholars based in United States, United Kingdom and Italy. Ezra E.W. Cohen's co-authors include Everett E. Vokes, Tanguy Y. Seiwert, Kerstin Stenson, Daniel J. Haraf, Loren K. Mell, Assuntina G. Sacco, Lisa Licitra, Steven I. Sherman, Mark W. Lingen and Lori J. Wirth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
In The Last Decade
Ezra E.W. Cohen
415 papers receiving 16.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ezra E.W. Cohen United States | 67 | 8.5k | 5.6k | 4.7k | 4.7k | 3.2k | 421 | 16.9k | ||
| Roger B. Cohen United States | 56 | 9.2k 1.1× | 5.9k 1.0× | 3.9k 0.8× | 5.4k 1.2× | 3.4k 1.0× | 328 | 17.5k | ||
| Lisa Licitra Italy | 63 | 8.1k 0.9× | 4.3k 0.8× | 6.2k 1.3× | 3.1k 0.7× | 5.9k 1.8× | 447 | 16.0k | ||
| William E. Gooding United States | 75 | 7.4k 0.9× | 4.3k 0.8× | 2.3k 0.5× | 5.0k 1.1× | 3.1k 1.0× | 283 | 17.2k | ||
| Bhuvanesh Singh United States | 59 | 5.7k 0.7× | 4.7k 0.8× | 1.8k 0.4× | 4.8k 1.0× | 3.2k 1.0× | 169 | 13.6k | ||
| Christine H. Chung United States | 52 | 5.6k 0.7× | 3.6k 0.6× | 7.2k 1.5× | 4.7k 1.0× | 4.5k 1.4× | 255 | 15.6k | ||
| Nancy Y. Lee United States | 65 | 6.1k 0.7× | 5.6k 1.0× | 9.0k 1.9× | 1.9k 0.4× | 7.4k 2.3× | 382 | 18.7k | ||
| Joseph A. Califano United States | 73 | 5.6k 0.7× | 2.5k 0.4× | 4.9k 1.0× | 9.2k 2.0× | 3.6k 1.1× | 357 | 18.9k | ||
| Merrill S. Kies United States | 57 | 7.3k 0.9× | 5.3k 1.0× | 5.7k 1.2× | 2.7k 0.6× | 5.2k 1.6× | 178 | 14.6k | ||
| Barbara Burtness United States | 56 | 8.5k 1.0× | 5.0k 0.9× | 5.0k 1.1× | 4.4k 1.0× | 3.7k 1.1× | 363 | 16.0k | ||
| William H. Westra United States | 73 | 9.8k 1.2× | 4.8k 0.9× | 16.4k 3.5× | 8.1k 1.7× | 10.9k 3.4× | 224 | 29.2k |
Countries citing papers authored by Ezra E.W. Cohen
Since
Specialization
Citations
This map shows the geographic impact of Ezra E.W. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezra E.W. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezra E.W. Cohen more than expected).
Fields of papers citing papers by Ezra E.W. Cohen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ezra E.W. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezra E.W. Cohen. The network helps show where Ezra E.W. Cohen may publish in the future.
Co-authorship network of co-authors of Ezra E.W. Cohen
This figure shows the co-authorship network connecting the top 25 collaborators of Ezra E.W. Cohen. A scholar is included among the top collaborators of Ezra E.W. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezra E.W. Cohen. Ezra E.W. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Brightman, Spencer E., Martin S. Naradikian, Pandurangan Vijayanand, et al.. (2025). The spontaneous neoantigen-specific CD4 + T-cell response to a growing tumor is functionally and phenotypically diverse. Journal for ImmunoTherapy of Cancer. 13(9). e012209–e012209.
2.
Hong, David S., Michael A. Postow, Bartosz Chmielowski, et al.. (2023). Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial. Clinical Cancer Research. 29(12). 2210–2219.
3.
Kim, Sangwoo S., Sarek Shen, Sayuri Miyauchi, et al.. (2020). B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade. Clinical Cancer Research. 26(13). 3345–3359.
4.
Harrington, Kevin J., Anthony Kong, Nicolas Mach, et al.. (2020). Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study. Clinical Cancer Research. 26(19). 5153–5161.
5.
Hingorani, Dina V., Maria F. Camargo, Joseph Aguilera, et al.. (2019). Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability. Molecular Cancer Therapeutics. 19(1). 157–167.
6.
Miyauchi, Sayuri, P. Dominick Sanders, Sangwoo S. Kim, et al.. (2019). HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer. Cancer Research. 80(4). 732–746.
7.
Husain, Hatim, Vladislava O. Melnikova, Karena Kosco, et al.. (2017). Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. Clinical Cancer Research. 23(16). 4716–4723.
8.
Cohen, Ezra E.W., Samuel J. LaMonte, Kerry L. Beckman, et al.. (2016). American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA A Cancer Journal for Clinicians. 66(3). 203–239.
9.
O’Donnell, Peter H., Theodore Karrison, Linda Janisch, et al.. (2015). Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide. Clinical Cancer Research. 21(22). 5092–5099.
10.
Sasaki, Mark M., Andrew D. Skol, Riyue Bao, et al.. (2015). Integrated Genomic Analysis Suggests MLL3 Is a Novel Candidate Susceptibility Gene for Familial Nasopharyngeal Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1222–1228.
11.
Elisei, Rossella, Martin Schlumberger, Stefan Müller, et al.. (2013). Cabozantinib in Progressive Medullary Thyroid Cancer. Journal of Clinical Oncology. 31(29). 3639–3646.
12.
Cohen, Ezra E.W., Kehua Wu, Christine Hartford, et al.. (2012). Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients. Clinical Cancer Research. 18(17). 4785–4793.
13.
Cohen, Ezra E.W., Daniel J. Haraf, Rangesh Kunnavakkam, et al.. (2010). Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 28(20). 3336–3343.
14.
Kuo, Wen‐Liang, Jing Liu, Helena J. Mauceri, et al.. (2010). Efficacy of the Multi-Kinase Inhibitor Enzastaurin Is Dependent on Cellular Signaling Context. Molecular Cancer Therapeutics. 9(10). 2814–2824.
15.
Chung, Christine H., Erin H. Seeley, Heinrich Röder, et al.. (2010). Detection of Tumor Epidermal Growth Factor Receptor Pathway Dependence by Serum Mass Spectrometry in Cancer Patients. Cancer Epidemiology Biomarkers & Prevention. 19(2). 358–365.
16.
Seiwert, Tanguy Y., Ramasamy Jagadeeswaran, Leonardo Faoro, et al.. (2009). The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Research. 69(7). 3021–3031.
17.
Dougherty, Urszula, Amikar Sehdev, Sandra Cerda, et al.. (2008). Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model. Clinical Cancer Research. 14(8). 2253–2262.
18.
Stewart, J.S.W., Ezra E.W. Cohen, Lisa Licitra, et al.. (2007). A Phase III randomized parallel-group study of gefitinib (IRESSA) versus methotrexate (IMEX) in patients with recurrent squamous cell carcinoma of the head and neck. Cancer Research. 67. 3522–3522.
19.
Ratain, Mark J. & Ezra E.W. Cohen. (2007). The Value Meal: How to Save $1,700 Per Month or More on Lapatinib. Journal of Clinical Oncology. 25(23). 3397–3398.
20.
Cohen, Ezra E.W., Mark W. Lingen, Bangmin Zhu, et al.. (2006). Protein Kinase Cζ Mediates Epidermal Growth Factor–Induced Growth of Head and Neck Tumor Cells by Regulating Mitogen-Activated Protein Kinase. Cancer Research. 66(12). 6296–6303.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Roger B. Cohen Breakdown of academic impact, for papers by Lisa Licitra Breakdown of academic impact, for papers by William E. Gooding Breakdown of academic impact, for papers by Bhuvanesh Singh Breakdown of academic impact, for papers by Christine H. Chung Breakdown of academic impact, for papers by Nancy Y. Lee Breakdown of academic impact, for papers by Joseph A. Califano Breakdown of academic impact, for papers by Merrill S. Kies Breakdown of academic impact, for papers by Barbara Burtness Breakdown of academic impact, for papers by William H. Westra